QUALITY CONTROL OF “MEKSI-SEEM” TABLETS
DOI:
https://doi.org/10.55640/Keywords:
“Meksi-SEEM” tablets, quality indicators, appearance, identity, average weight, disintegration, quantitative analysis, dissolution, microbiological purity.Abstract
In this article, the results of scientific research on the quality assessment of the “Meksi-SEEM” tablets recommended for use in neurological disorders are presented [1]. For the first time, the technology of coated tablets was studied based on scientific investigations. The quality indicators of the tablet were evaluated in accordance with the relevant Normative document (ND).
Downloads
References
1.Jankovic J., Mazziotta J.C., Newman N.J., Pomeroy S.L. Research in the Diagnosis and Treatment of Neurological Disorders. In: Jankovic J., Mazziotta J.C., Pomeroy S.L., Newman N.J., eds. Bradley and Daroff’s Neurology in Clinical Practice. 8th ed. Philadelphia, Pennsylvania: Elsevier; 2022.
2.State Pharmacopoeia of the Republic of Uzbekistan. First Edition. Vol. I, Part 1. Tashkent: “Sharq” Publishing House, 2021. – 605 p.
3.Madraximov Sh.N., Rakhimova O.R., Khalilov R.M., Kotenko L.D., Rakhimova G.R. Development of the Technology and Quality Evaluation of Ferulen Tablets. Pharmaceutical Journal, 2016, No. 4, pp. 63–68.
4.Atajanov N.R., Karayeva N.Y., Tadjieva A.D. Determination of shelf life of MKS-LR (BAA) tablets. Ethiopian International Journal of Multidisciplinary Research” journal. Volume 11, Issue 05. 2024. P.750-753.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India